Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +5.95% shed 3.76% to $167.52 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +3.82% falling 1.30% to 14,154.02 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.47% falling 0.89% to 34,715.39. This was the stock's fifth consecutive day of losses. Moderna Inc. closed $329.97 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.51% fell 1.61% to $133.03, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.54% fell 1.04% to $228.90, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.75% rose 1.16% to $60.17. Trading volume (11.4 M) eclipsed its 50-day average volume of 11.2 M.